stars 1 stars 2 stars 3

NextCell Pharma is an innovative Biotech growing out of the need for Advanced Therapy Medicinal Products for Autoimmune Disease and Transplantation. Cellaviva, the first Swedish family saving stem cell bank, with its expertise in umbilical cord stem cells and Diamyd Medical with its interests and investments within autoimmune diseases made a natural partnership for creating NextCell Pharma. Clinical trials testing NextCell Pharma’s first product, ProTrans,has started in Novermber 2018. #nextcellpharma #cellaviva

NextCell Pharma AB Questions

The NextCell Pharma AB annual revenue was $6 million in 2026.

Mathias Svahn is the CEO of NextCell Pharma AB.

12 people are employed at NextCell Pharma AB.

NextCell Pharma AB is based in Huddinge, Stockholm County.

The NAICS codes for NextCell Pharma AB are [32541, 32, 3254, 325].

The SIC codes for NextCell Pharma AB are [283, 28].

Top NextCell Pharma AB Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users